← All trials
NCT05777278
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 26, 2023
- Primary completion
- Aug 31, 2027
- Completion date
- Aug 31, 2027
- First posted
- Mar 21, 2023
- Last posted
- Oct 10, 2023
- Enrollment
- 29
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangzhou Medical UniversityLead sponsor
- Guangzhou Medical UniversityOverall official - principal investigator
- Guangzhou Medical UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.